Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral Therapy
Top Cited Papers
Open Access
- 1 June 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (11), 1694-1701
- https://doi.org/10.1086/587667
Abstract
Background. Cryptococcal meningitis (CM) is the proximate cause of death in 20%–30% of persons with acquired immunodeficiency syndrome in Africa.MethKeywords
This publication has 30 references indexed in Scilit:
- Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or FluconazoleClinical Infectious Diseases, 2007
- Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural UgandaTropical Medicine & International Health, 2007
- Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D StudyPLoS Medicine, 2007
- Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapyAIDS, 2006
- The Role of Immune Reconstitution Inflammatory Syndrome in AIDS‐RelatedCryptococcus neoformansDisease in the Era of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2005
- Managing Cryptococcal Meningitis Is about Handling the PressureClinical Infectious Diseases, 2005
- A multicentre, randomized, double‐blind, placebo‐controlled trial of primary cryptococcal meningitis prophylaxis in HIV‐infected patients with severe immune deficiencyHIV Medicine, 2004
- Practice Guidelines for the Management of Cryptococcal DiseaseClinical Infectious Diseases, 2000
- Cryptococcal meningitis in Lilongwe and Blantyre, MalawiJournal of Infection, 1994
- Infections withCryptococcus neoformansin the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989